Today 2026.04.25
We express our deepest respect for your commitment to improving public health through pharmaceutical research and development. We sincerely wish continued success and prosperity of your company.
Thanks to your continuous interest and cooperation, The Korean Academy of Family Medicine (KAFM) has grown into an influential medical society with over 10,000 members, playing a pivotal role in primary care in Korea. Also, we are grateful for your support in our recent Spring and Autumn online conference, which successfully facilitated the exchange of medical knowledge with about 1,000 members participating in each session.
KAFM has been hosted academic conferences bi-annually, every spring and fall. The 3rd International Congress on Primary Care (ICPC 2026) and 2026 Annual Spring Conference of the Korean Academy of Family Medicine will be held from April 24(Fri) to April 26(Sun) at Suwon Convention Center, Korea. We are certain that ICPC 2026 will be an excellent platform to effectively promote your company and products to medical professionals from various fields.
Sponsorship opportunity is available through various programs – including Symposia, Sponsored Lectures, Exhibition Booths, Journal Advertisements, Conference Kits, and Website Banners and more. You can find more specific details in the attached document.
For detailed inquiries regarding sponsorship program, please contact us at:
You can apply for sponsorship on the KAFM website - please note that the issuance of documents (invoices, receipts, etc.) and the booth location selection will be conducted online as well. Detailed information is available on the ‘KAFM Conference Sponsorship’ page via the link below.
We kindly ask for your favorable consideration of this sponsorship. Should you have any question regarding sponsorship program, we would be pleased to meet you to discuss them further. In this regard, KAFM guarantees strict adherence to your company’s internal ethical guideline, as well as the code of conduct and fair-trade regulations set forth by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and the Korean Research-based Pharma Industry Association (KRPIA).